Overview of Dr. Vasan
Dr. Neil Vasan is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Yale School of Medicine and has been in practice 3 years. He is one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 370 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032Fax+1 212-305-0178
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
Yale School of MedicineClass of 2013
Certifications & Licensure
NY State Medical License 2015 - 2027
NJ State Medical License 2020 - 2021
MA State Medical License 2013 - 2015
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsMapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens.Zachary H Walsh, Parin Shah, Neeharika Kothapalli, Shivem B Shah, Gergo Nikolenyi
Nature Biotechnology. 2025-03-01 - Use of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer.Claire Sathe, Rohit Raghunathan, Sophie Ulene, Fiona McAuley, Kishan A Bhatt
JCO Oncology Practice. 2025-02-01 - LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models.Alice E Shin, Kensuke Sugiura, Secunda W Kariuki, David A Cohen, Samuel P Flashner
The Journal of Clinical Investigation. 2025-01-14
Press Mentions
Navigating the Evolving Landscape of ER-Positive Metastatic Breast Cancer TreatmentJanuary 6th, 2025- Year in Review Session Summarizes Important Breast Cancer Takeaways from 2024December 15th, 2024
- Special Session Explores Considerations Behind Breast Cancer Drug Approvals, TrialsDecember 15th, 2024
- Join now to see all
Grant Support
- Base-Editing the Cancer Kinome to Enable Drug DiscoveryCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2026
- Investigating a hierarchical model for PI3K activation and inhibition in breast cancer by double PIK3CA mutations in cisCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Investigating a hierarchical model for PI3K activation and inhibition in breast cancer by double PIK3CA mutations in cisCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
